Laboratory study of HIV-1 and HTLV-I/II coinfection
- PMID: 7852953
- DOI: 10.1002/jmv.1890440205
Laboratory study of HIV-1 and HTLV-I/II coinfection
Abstract
A Retroviral Coinfection Clinic was established in 1991 at Charity Hospital Medical Center of Louisiana to study patients dually infected with human immunodeficiency virus (HIV) and human T lymphotropic virus (HTLV-I, HTLV-II). Eight patients were evaluated clinically, and by immunological and virological studies. Multiple neuromuscular diseases were observed, including tropical spastic paraparesis, polymyositis, and polyneuropathies. Only one patient developed AIDS. HIV-1 infected patients with HTLV-I, but not HTLV-II, coinfection have maintained stable CD4 counts, despite the fact that quantitative HIV DNA PCR suggests a relatively high copy number. HTLV-I/II antigens were detected in lymphocyte cultures from four patients, and lymphoblastoid cell lines have been established from two. These results support the contention that upregulated HTLV-I/II virus expression and disease manifestations occur during coinfection with HIV, sometimes in association with normal CD4 counts.
Similar articles
-
High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.J Med Virol. 2015 May;87(5):790-7. doi: 10.1002/jmv.24070. Epub 2015 Feb 10. J Med Virol. 2015. PMID: 25678365
-
[Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].Rev Soc Bras Med Trop. 2009 May-Jun;42(3):264-70. doi: 10.1590/s0037-86822009000300006. Rev Soc Bras Med Trop. 2009. PMID: 19684973 Portuguese.
-
Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.Clin Infect Dis. 2007 May 1;44(9):1229-34. doi: 10.1086/513428. Epub 2007 Mar 19. Clin Infect Dis. 2007. PMID: 17407044
-
Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.AIDS Rev. 2007 Jul-Sep;9(3):140-9. AIDS Rev. 2007. PMID: 17982939 Review.
-
Human T-lymphotropic virus/HIV co-infection: a clinical review.Curr Opin Infect Dis. 2014 Feb;27(1):16-28. doi: 10.1097/QCO.0000000000000027. Curr Opin Infect Dis. 2014. PMID: 24305042 Review.
Cited by
-
In vivo interactions of ecotropic and polytropic murine leukemia viruses in mixed retrovirus infections.J Virol. 2006 May;80(10):4748-57. doi: 10.1128/JVI.80.10.4748-4757.2006. J Virol. 2006. PMID: 16641268 Free PMC article.
-
Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathy.J Virol. 1998 Sep;72(9):7664-8. doi: 10.1128/JVI.72.9.7664-7668.1998. J Virol. 1998. PMID: 9696872 Free PMC article.
-
Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro.J Med Virol. 2008 Mar;80(3):494-500. doi: 10.1002/jmv.21089. J Med Virol. 2008. PMID: 18205225 Free PMC article.
-
Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.Springer Semin Immunopathol. 2006 Nov;28(3):281-7. doi: 10.1007/s00281-006-0045-0. Epub 2006 Oct 13. Springer Semin Immunopathol. 2006. PMID: 17109182 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials